戻る Agenda
Session 5 Users’ Experiences and Perspectives Regarding Biosimilars and Considerations on National Policy Developments
Session Chair(s)
Sabine Atzor, MPHARM, RPH
Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland
Suzette Kox, MPHARM
Senior Director International-Biosimilars Medicines Group
Medicines for Europe, Belgium
The session will continue by giving floor to health care professionals and patients and their points of view on the policy developments.
Speaker(s)
Carl-Erik Flodmark
Childhood Obesity Unit Region Skane, Sweden
Chief medical officer at Childhood
Biosimilars in Clinical Practice: the Perspective of the Hospital Pharmacist
Thijs Giezen, PHARMD, PHD, MSC
Medicines Evaluation Board, Netherlands
Patients' perspectives
Marco Greco, PHD
European Patients' Forum, Belgium
President
Payer's perspective
Margaret Dolan
NHS Commercial Solutions, United Kingdom
Regional Pharmacy Procurement Specialist